The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
The Contract Research Organization and the Commercialization of Scientific Research
Abstract
The early 1980s constituted a watershed in science, mainly concerning the extent and nature of globalization and commercialization of scientific research, and its impact upon the university. Considerable debate has arisen about the sources of this transition, but aside from a few lone voices, the scholarly literature has neglected the concurrent rise of the contract research organization (CRO) and its role in the commercialization of scientific research. The CRO warrants wider attention as a modern paradigm of privatized science in the biopharmaceutical sector. In discussing the CRO’s technologies, the purposes they pursue, and the legal and policy initiatives that have fostered their rapid rise, we confront the wider implications of the modern regime of commercialized science for the future conduct of scientific research. We identify five areas of innovation: treatment of human subjects, control of disclosure, subjection of research tools to commercialization, redefinition of authorship, and re-engineering the goals of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can Patents Deter Innovation? The Anticommons in Biomedical Research
Heller, M. A., & Eisenberg, R. S. (1998) · Science · doi:10.1126/science.280.5364.698 · Cited by 2,572
Toward a new economics of science
Partha, D., & David, P. A. (1994) · Research Policy · doi:10.1016/0048-7333(94)01002-1 · Cited by 2,448
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“One recent examination of published surveys and meta-analyses of drug efficacy found that ‘[s]tudies sponsored by pharmaceutical companies were more likely to have outcomes favoring the sponsor than were studies with other sponsors’ (Lexchin et al., 2003: 1167).”
ResultScope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816
Bernstein, H. L., Horowitz, D. L., Lange, D. L., Powell, H. J., Shimm, M. G., Weistart, J. C., Danner, R. A., Germain, C., Baccari, B. A., Eichhorn, L. A., et al. (1990) · Cited by 1,803
Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?
Wazana, A. (2000) · JAMA · doi:10.1001/jama.283.3.373 · Cited by 1,415
Universities in the marketplace: the commercialization of higher education
(2003) · Choice Reviews Online · doi:10.5860/choice.41-1047 · Cited by 1,321
Vanderbilt Journal of Transnational Law
Finch, E. H. (1972) · American Journal of International Law · doi:10.1017/s0002930000206908 · Cited by 1,190
Information Feudalism: Who Owns the Knowledge Economy?
Ingram, M. C., Drahos, P., & Braithwaite, J. (2003) · Contemporary Sociology · doi:10.2307/1556517 · Cited by 826
Private Power, Public Law: The Globalization of Intellectual Property Rights
Sell, S. K. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511491665 · Cited by 768
Research works printed but not linked: 83
- 10.1057/9780230372597 · doi:10.1057/9780230372597
- Agres, Ted, 2003, The Scientist, 17, 58
- Angell, Marcia, 2002, Daedalus, 102
- Azoulay, Pierre, 2002, ‘Acquiring Knowledge Within and Across Firm Boundaries’
- 10.3386/w10142 · doi:10.3386/w10142
- 10.1126/science.1087592 · doi:10.1126/science.1087592
- Berenson, Alex, 2004, New York Times, A1
- Bogdanich, Walt, 2002, Bill Moyers Now
- Breitstein, Joanna, 2001, Pharmaceutical Executive
- Croissant, Jennifer, 2001, Degrees of Compromise: Industrial Interests and Academic Values
- Datta, P., 2003, Financial Times
- Davies, Helen, Institute of Medicine on 21 August
- Davies, Helen, DIA 2002 Annual Meeting
- DeYoung, Karen, 2000, Washington Post
- Drahos, Peter, 2002, Information Feudalism
- 10.1016/S1359-6446(01)02137-7 · doi:10.1016/s1359-6446(01)02137-7
- Dreyfuss, Rachel, 2001, Expanding the Boundaries of Intellectual Property, 10.1093/oso/9780198298571.001.0001 · doi:10.1093/oso/9780198298571.001.0001
- Eisenberg, Rebecca, 2001, Expanding the Boundaries of Intellectual Property, 223, 10.1093/oso/9780198298571.003.0009 · doi:10.1093/oso/9780198298571.003.0009
- Eisenberg, Rebecca, 2003, Law and Contemporary Problems, 56, 289
- Elliott, Carl, 2002, London Review of Books, 36
- 10.1126/science.284.5419.1445b · doi:10.1126/science.284.5419.1445b
- 10.1353/pbm.2003.0020 · doi:10.1353/pbm.2003.0020
- 10.1007/978-1-4615-0981-3 · DOI
- Flaherty, Mary P., 2000, Washington Post, A1
- Forster, David, 2002, Seton Hall Law Review, 32, 513
- 2002, FY 2003 President’s Budget for Department of Health and Human Services
- Gad, Shane C., 2003, The Selection and Use of Contract Research Organizations
- Giombetti, Ric, 2002, ‘Suicide Science - Paxil’s Friendly Ghostwriter?’
- Goliszek, Andrew, 2003, In the Name of Science
- Greenberg, Daniel, 2001, Science, Money and Politics
- 10.1007/s11948-003-0020-2 · doi:10.1007/s11948-003-0020-2
- Hope, Janet, 2003, ‘Intellectual Property and the Biotechnology Revolution’
- Hughes, Graham, 2002, European Pharmaceutical Contractor
- Hughes, Sue, 2002, Heartwire
- Johnson, Erica, 2003, CBC Marketplace
- Kahin, Brian, 2001, First Monday, 6
- Kessler, David, 2001, A Question of Intent
- Kevles, Daniel, 1994, Historical Studies in the Physical and Biological Sciences, 25, 111, 10.2307/27757736 · doi:10.2307/27757736
- Krimsky, Sheldon, 2003, Science in the Private Interest
- Kunin, Stephen, 2002, American University Law Journal, 51, 608
- 10.1016/S0041-1345(03)00203-3 · doi:10.1016/s0041-1345(03)00203-3
- Lemonick, Michael, 2000, Time, 46
- 10.1080/1042771042000187907 · doi:10.1080/1042771042000187907
- Lessig, Larry, 2001, The Future of Ideas
- Lester, David, 2003, American Pharmaceutical Outsourcing
- McSherry, Corynne, 2001, Who Owns Academic Work?
- Magnus, David, 2002, Who Owns Life?
- Marks, Harry, 1997, The Progress of Experiment
- Maurer, Stephen, NRC Symposium on Information in the Public Domain
- Meier, Barry, 2004, New York Times, A1
- Milne, C., 2004, American Pharmaceutical Outsourcing
- Mirowski, Philip, 2001, First Monday
- Mirowski, Philip, 2002, Science Bought and Sold
- 10.1002/1099-1050(200012)9:8<659::AID-HEC578>3.0.CO;2-0 · doi:10.1002/1099-1050(200012)9:8<659::aid-hec578>3.0.co;2-0
- 10.1023/A:1007875910066 · doi:10.1023/a:1007875910066
- 10.1215/9780822385202 · doi:10.1215/9780822385202
- Newman, Nathan, 2002, Nation
- Nowotny, Helga, 2001, Rethinking Science
- Okie, Susan, 2001, Washington Post, A11
- Parexel, 2003, Pharmaceutical R&D Statistical Sourcebook
- Pear, Robert, 2003, New York Times
- 10.1016/S0166-4972(01)00081-5 · doi:10.1016/s0166-4972(01)00081-5
- Pollack, Andrew, 2002, New York Times
- Pollack, Andrew, 2004, New York Times, 1
- Pomfret, John, 2000, Washington Post
- Posner, Richard A., 2002, Daedalus, 5
- Press, Eyal, 2000, Atlantic Monthly, 285, 39
- Public Citizen Health Research Group, 2001, ‘Rx R&D Myths: The Case Against the Drug Industry’s R&D “Scare Card”’
- 10.1023/A:1015760920428 · doi:10.1023/a:1015760920428
- Reimers, Niels, 1998, Oral History
- Roman, Joanne, 2002, Cornell Journal of Law and Public Policy, 11, 441
- 10.1093/hmg/10.20.2261 · doi:10.1093/hmg/10.20.2261
- Ryan, Michael, 1998, Knowledge Diplomacy
- 10.1097/00001888-200212001-00006 · doi:10.1097/00001888-200212001-00006
- Shapin, Steven, 2003, London Review of Books, 15
- Sharma, B.L., 2003, Associated Press Worldstream
- Siegel, Marc, 2002, Nation
- Stephens, Joseph, 2000, Washington Post
- Stone, T. Howard, 2003, Currents in Contemporary Ethics, 31, 149
- Streitz, Wendy D., 2003, ‘Material Transfer Agreements: A Win-Win for Academia and Industry’ (Power Point presentation)
- 10.1016/S0041-1345(03)00202-1 · doi:10.1016/s0041-1345(03)00202-1
- Wilson, Duff, 2001, Seattle Times
- Zuckerman, Diana, 2002, Extra!
Cited by
Conflict of Interest in Medical Research, Education, and Practice
(2009) · National Academies Press eBooks · doi:10.17226/12598 · Cited by 807
Medical Micro/Nanorobots in Precision Medicine
Soto, F., Wang, J., Ahmed, R., & Demirci, U. (2020) · Advanced Science · doi:10.1002/advs.202002203 · Cited by 442
Ghosts in the Machine: Publication Planning in the Medical Sciences
Sismondo, S. (2009) · Social Studies of Science · doi:10.1177/0306312708101047 · Cited by 297
Sismondo, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040286 · Cited by 259
Introduction: STS and Neoliberal Science
Lave, R., Mirowski, P., & Randalls, S. (2010) · Social Studies of Science · doi:10.1177/0306312710378549 · Cited by 256
Self-citation
Metadata
- Authors
- Mirowski, P., & Van Horn, R.
- Venue
- Social Studies of Science
- Publisher
- SAGE Publications
- Published
- 2005-08
- Volume
- 35
- Issue
- 4
- Pages
- 503-548
- ISSN
- 0036-8539 (ISSN-L)
- 0306-3127
- 1460-3659
- OpenAlex
- W2172194321
- Cited by
- 260
- References
- 78
- FWCI
- 34.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Contract Research Organization and the Commercialization of Scientific Research. https://app.cochat.ai/papers/10.1177/0306312705052103
- The paper
- Mirowski, P., & Van Horn, R. (2005). The Contract Research Organization and the Commercialization of Scientific Research. Social Studies of Science. https://doi.org/10.1177/0306312705052103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.